Calcitonin vs GHK-Cu
Overview
Calcitonin is primarily a bone & joint peptide, while GHK-Cu is used for pain management.
This page compares Calcitonin and GHK-Cu across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Calcitonin | GHK-Cu | |
|---|---|---|
| Category | Bone & Joint | Pain Management |
| Regulatory status (US) | Research use only | Compounding (Rx) — Apr 2026 |
| Typical dosage | 100-200 IU | 1-3 mg |
| Frequency | daily | daily |
| Reported benefits | Reduced bone loss, pain relief in bone diseases | Pain reduction through healing, anti-inflammatory, tissue regeneration |
| Reported side effects | Nasal irritation (spray form), nausea | Minimal side effects |
Key differences
Primary use. Calcitonin is categorised under Bone & Joint, while GHK-Cu falls under Pain Management. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Calcitonin: not FDA-approved; treated as a research compound. GHK-Cu: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Calcitonin is typically dosed at 100-200 IU (daily). GHK-Cu is typically dosed at 1-3 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Calcitonin and GHK-Cu has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Calcitonin and GHK-Cu?
- Calcitonin is primarily a bone & joint peptide, while GHK-Cu is used for pain management. Calcitonin is not FDA-approved; generally classified as a research compound, whereas GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Calcitonin used for?
- FDA-approved bone resorption inhibitor.
- What is GHK-Cu used for?
- Anti-inflammatory tissue repair.
- Can you take Calcitonin and GHK-Cu together?
- Some users combine peptides within a single protocol, but stacking Calcitonin and GHK-Cu has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Calcitonin or GHK-Cu FDA-approved?
- Calcitonin is not FDA-approved; generally classified as a research compound. GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Calcitonin — full monograph: mechanism, research, dosing & references
- GHK-Cu — full monograph: mechanism, research, dosing & references